Crossmark

A novel compound heterozygous mutation in VARS2 in a newborn with mitochondrial cardiomyopathy: a case report of a Chinese family

Crossref DOI link: https://doi.org/10.1186/s12881-018-0689-3

Published Online: 2018-11-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Keze

Xie, Mingyu

He, Xiaoguang

Liu, Guojun

Lu, Xiaomei

Peng, Qi

Zhong, Baimao

Li, Ning https://orcid.org/0000-0003-4768-9098
Funding

Funding for this research was provided by:

Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (2014108101027)

Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (2015108101031)
License Information

Text and Data Mining valid from 2018-11-20
More Information

Article History

Received: 11 June 2018

Accepted: 20 September 2018

First Online: 20 November 2018

Ethics approval and consent to participate

: The study was approved by the Ethics Committee of Dongguan Children’s Hospital in agreement with the Declaration of Helsinki. Informed consent was obtained from the parents of the study subject.

: All members of the family signed a written consent form for publication of all data.

: ᅟ

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.